UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

Oncotarget, 2018-05, Vol.9 (41), p.26406-26416

2018

Volltextzugriff (PDF)

Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia

Cancer, 2004-06, Vol.100 (11), p.2462-2469

2004

Volltextzugriff (PDF)

Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications

Frontiers in oncology, 2019-10, Vol.9, p.1124-1124

2019

Volltextzugriff (PDF)

Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index

Breast cancer research : BCR, 2013-10, Vol.15 (5), p.R98-R98, Article R98

2013

Volltextzugriff (PDF)

Role of poly-ADP-ribose polymerase inhibitors after brain progression in platinum-sensitive ovarian cancer: a case report and review of the literature

Frontiers in oncology, 2024-08, Vol.14, p.1423992

2024

Volltextzugriff (PDF)

Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients

JNCI : Journal of the National Cancer Institute, 2017-01, Vol.109 (4), p.djw265

2017

Volltextzugriff (PDF)

Targeted treatment approaches in refractory germ cell tumors

Critical reviews in oncology/hematology, 2019-11, Vol.143, p.130-138

2019

Volltextzugriff (PDF)

Time to diagnosis of ewing tumors in children and adolescents is not associated with metastasis or survival

Journal of clinical oncology, 2014-12, Vol.32 (35), p.4020-4020

2014

Volltextzugriff (PDF)

Late Administration of Trastuzumab Emtansine Might Lead to Loss of Chance for Better Outcome in Patients with HER2-Positive Metastatic Breast Cancer

Breast care (Basel, Switzerland), 2018-08, Vol.13 (4), p.277-283

2018

Volltextzugriff (PDF)

Lights and shadows of the tumoral marker CA-125 in ovarian cancer

Clinical & translational oncology, 2008-08, Vol.10 (8), p.449-452

2008

Volltextzugriff (PDF)

High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9124

2022

Volltextzugriff (PDF)

Adjuvant high-dose interferon therapy for melanoma: nothing has really changed

Melanoma research, 2014-10, Vol.24 (5), p.522-523

2014

Volltextzugriff (PDF)

Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

Journal of clinical oncology, 2011-12, Vol.29 (35), p.4677-4681

2011

Volltextzugriff (PDF)

18F-FDG-PET/CT in predicting pathologic complete response after neoadjuvant chemotherapy: The early metabolic response is the answer

European journal of cancer (1990), 2013-11, Vol.49 (16), p.3573-3574

2013

Volltextzugriff (PDF)

Response to paclitaxel in a radiotherapy-induced breast angiosarcoma

Acta oncologica, 2009, Vol.48 (7), p.1078-1079

2009

Volltextzugriff (PDF)

Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma

Biomedicines, 2022-09, Vol.10 (10), p.2419

2022

Volltextzugriff (PDF)

Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer

BMC cancer, 2010-04, Vol.10 (1), p.136-136, Article 136

2010

Volltextzugriff (PDF)

Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients

European journal of cancer (1990), 2021-02, Vol.144, p.224-231

2021

Volltextzugriff (PDF)

Negative Prognostic Impact of the Coexpression of Epidermal Growth Factor Receptor and c-erbB-2 in Locally Advanced Cervical Cancer

Oncology, 2009-01, Vol.76 (2), p.133-141

2009

Volltextzugriff (PDF)

Targeted therapies in the treatment of germ cell tumors: The need for new approaches against “orphan” tumors

Critical reviews in oncology/hematology, 2012-09, Vol.83 (3), p.444-451

2012

Volltextzugriff (PDF)

Proliferation Determined by ki67 Marker and pCR in Locally Advanced Breast Cancer Patients Treated with Neo-adjuvant Chemotherapy

The breast journal, 2013-11, Vol.19 (6), p.685-686

2013

Volltextzugriff (PDF)

Experience with eribulin in triple-negative metastatic breast cancer: case studies

Future oncology (London, England), 2018-03, Vol.14 (7s), p.13-20

2018

Volltextzugriff (PDF)

Initialization of adjuvant hormonal treatment for breast cancer

Advances in therapy, 2011-09, Vol.28 (Suppl 6), p.66-84

2011

Volltextzugriff (PDF)

Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes

Modern pathology, 2018-02, Vol.31 (2), p.299-306

2018

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(81)
Spanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(57)
Humans
(48)
Oncology
(42)
Female
(38)
Middle Aged
(29)
Adult
(27)
Aged
(26)
Male
(15)
Medicine
(15)
Medicine & Public Health
(14)
Breast Neoplasms - Drug Therapy
(13)
Prognosis
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Breast Cancer
(12)
Follow-Up Studies
(11)
Treatment Outcome
(11)
Biological And Medical Sciences
(10)
Disease-Free Survival
(10)
Medical Sciences
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia

Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications

Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index

Role of poly-ADP-ribose polymerase inhibitors after brain progression in platinum-sensitive ovarian cancer: a case report and review of the literature

Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients

Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data

Targeted treatment approaches in refractory germ cell tumors

Time to diagnosis of ewing tumors in children and adolescents is not associated with metastasis or survival

Late Administration of Trastuzumab Emtansine Might Lead to Loss of Chance for Better Outcome in Patients with HER2-Positive Metastatic Breast Cancer

Lights and shadows of the tumoral marker CA-125 in ovarian cancer

High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade

Adjuvant high-dose interferon therapy for melanoma: nothing has really changed

Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

18F-FDG-PET/CT in predicting pathologic complete response after neoadjuvant chemotherapy: The early metabolic response is the answer

Response to paclitaxel in a radiotherapy-induced breast angiosarcoma

Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma

Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer

Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients

Negative Prognostic Impact of the Coexpression of Epidermal Growth Factor Receptor and c-erbB-2 in Locally Advanced Cervical Cancer

Targeted therapies in the treatment of germ cell tumors: The need for new approaches against “orphan” tumors

Proliferation Determined by ki67 Marker and pCR in Locally Advanced Breast Cancer Patients Treated with Neo-adjuvant Chemotherapy

Experience with eribulin in triple-negative metastatic breast cancer: case studies

Initialization of adjuvant hormonal treatment for breast cancer

Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes

Suchergebnisse filtern